Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Infant Immunity after Maternal Nipocalimab in Severe Hemolytic Disease of the Fetus and Newborn.
Journal: NEJM evidence
Published: January 27, 2026
Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn.
Journal: The New England journal of medicine
Published: August 08, 2024
Prospective, randomized, double-blind, placebo-controlled evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia.
Journal: American journal of obstetrics and gynecology
Published: February 24, 2020
M281, an Anti-FcRn Antibody: Pharmacodynamics, Pharmacokinetics, and Safety Across the Full Range of IgG Reduction in a First-in-Human Study.
Journal: Clinical pharmacology and therapeutics
Published: August 17, 2018
Clinical syndromes associated with acquired antithrombin deficiency via microvascular leakage and the related risk of thrombosis.
Journal: Thrombosis research
Published: October 25, 2013
Patterns and predictors of change in outcome measures in clinical trials in scleroderma: an individual patient meta-analysis of 629 subjects with diffuse cutaneous systemic sclerosis.
Journal: Arthritis and rheumatism
Published: February 14, 2012
Showing 1-6 of 6
Last Updated: 09/26/2026